SK3796A3 - Process for the synthesis of azetidinones - Google Patents

Process for the synthesis of azetidinones Download PDF

Info

Publication number
SK3796A3
SK3796A3 SK37-96A SK3796A SK3796A3 SK 3796 A3 SK3796 A3 SK 3796A3 SK 3796 A SK3796 A SK 3796A SK 3796 A3 SK3796 A3 SK 3796A3
Authority
SK
Slovakia
Prior art keywords
phenyl
group
substituted
lower alkyl
benzyl
Prior art date
Application number
SK37-96A
Other languages
English (en)
Slovak (sk)
Inventor
Tiruvertipuram K Thiruvengadam
Timothy Mcallister
Chou-Hong Tann
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22217215&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK3796(A3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of SK3796A3 publication Critical patent/SK3796A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SK37-96A 1993-07-09 1994-07-01 Process for the synthesis of azetidinones SK3796A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8935793A 1993-07-09 1993-07-09
PCT/US1994/007291 WO1995001961A1 (en) 1993-07-09 1994-07-01 Process for the synthesis of azetidinones

Publications (1)

Publication Number Publication Date
SK3796A3 true SK3796A3 (en) 1997-02-05

Family

ID=22217215

Family Applications (1)

Application Number Title Priority Date Filing Date
SK37-96A SK3796A3 (en) 1993-07-09 1994-07-01 Process for the synthesis of azetidinones

Country Status (21)

Country Link
US (1) US5728827A (cs)
EP (1) EP0707567B1 (cs)
JP (1) JP2840452B2 (cs)
KR (1) KR0176001B1 (cs)
CN (1) CN1071745C (cs)
AT (1) ATE205475T1 (cs)
AU (1) AU681419B2 (cs)
CA (1) CA2166784C (cs)
CZ (1) CZ7696A3 (cs)
DE (1) DE69428280T2 (cs)
DK (1) DK0707567T3 (cs)
ES (1) ES2160125T3 (cs)
FI (1) FI960095A7 (cs)
HU (1) HUT73237A (cs)
MX (1) MX9405152A (cs)
NO (1) NO306294B1 (cs)
NZ (1) NZ268798A (cs)
PL (1) PL312502A1 (cs)
PT (1) PT707567E (cs)
SK (1) SK3796A3 (cs)
WO (1) WO1995001961A1 (cs)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631365A (en) 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6207822B1 (en) 1998-12-07 2001-03-27 Schering Corporation Process for the synthesis of azetidinones
CA2353981C (en) * 1998-12-07 2005-04-26 Schering Corporation Process for the synthesis of azetidinones
AU4343500A (en) 1999-04-16 2000-11-02 Schering Corporation Use of azetidinone compounds
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en) 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
KR20070120617A (ko) 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
BRPI0208384B1 (pt) 2001-03-28 2016-05-31 Merck Sharp & Dohme síntese enantiosseletiva de compostos intermediários de azetidinona
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
EP1429756B1 (en) * 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
US20030204096A1 (en) * 2002-03-25 2003-10-30 Schering Corporation Enantioselective synthesis of azetidinone intermediate compounds
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
US7135556B2 (en) * 2002-07-19 2006-11-14 Schering Corporation NPC1L1 (NPC3) and methods of use thereof
CA2504916A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
DE602004018617D1 (de) * 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
WO2004081002A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081004A1 (en) 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP2007516287A (ja) * 2003-12-23 2007-06-21 メルク エンド カムパニー インコーポレーテッド 抗高コレステロール血症化合物
ATE485267T1 (de) 2003-12-23 2010-11-15 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
JP4590417B2 (ja) * 2004-01-16 2010-12-01 メルク・シャープ・エンド・ドーム・コーポレイション Npc1l1(npc3)およびこのリガンドの同定方法
DE102004025071B4 (de) * 2004-05-21 2006-12-21 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Diphenylazetidinon-Derivaten
TW200611896A (en) * 2004-05-21 2006-04-16 Aventis Pharma Gmbh Process for preparing 1, 4-diphenylazetidinone derivatives
US20060135755A1 (en) * 2004-12-20 2006-06-22 Schering Corporation Process for the synthesis of azetidinones
DE602006010870D1 (de) * 2005-06-20 2010-01-14 Schering Corp Als antagonisten von histamin h3 geeignete piperidinderivate
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
US7910698B2 (en) * 2006-02-24 2011-03-22 Schering Corporation NPC1L1 orthologues
AR060623A1 (es) 2006-04-27 2008-07-02 Astrazeneca Ab Compuestos derivados de 2-azetidinona y un metodo de preparacion
WO2008030382A1 (en) * 2006-09-05 2008-03-13 Schering Corporation Pharmaceutical combinations for lipid management and in the treatment of atherosclerosis and hepatic steatosis
WO2008032338A2 (en) * 2006-09-11 2008-03-20 Manne Satyanarayana Reddy Improved process for the preparation of ezetimibe and its intermediates
WO2008089984A2 (en) 2007-01-24 2008-07-31 Krka Process for the preparation of ezetimibe and derivatives thereof
EP2414529A2 (en) 2009-04-01 2012-02-08 Matrix Laboratories Ltd Enzymatic process for the preparation of (s)-5-(4-fluoro-phenyl)-5-hydroxy- 1morpholin-4-yl-pentan-1-one, an intermediate of ezetimibe and further conversion to ezetimibe
CN104803858B (zh) * 2014-01-23 2019-03-01 东莞东阳光科研发有限公司 一种制备四丁基氟化铵三水合物的方法
PT4097099T (pt) 2020-02-07 2024-07-19 Gasherbrum Bio Inc Agonistas heterocíclicos de glp-1
WO2022052958A1 (en) 2020-09-10 2022-03-17 Gasherbrum Bio, Inc. Heterocyclic glp-1 agonists
KR20250168210A (ko) 2023-02-16 2025-12-02 가셔브룸 바이오, 인크. 헤테로시클릭 glp-1 효능제

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0333268A1 (en) * 1988-03-18 1989-09-20 Merck & Co. Inc. Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US4876365A (en) * 1988-12-05 1989-10-24 Schering Corporation Intermediate compounds for preparing penems and carbapenems
US4983597A (en) * 1989-08-31 1991-01-08 Merck & Co., Inc. Beta-lactams as anticholesterolemic agents
US5085473A (en) * 1990-10-09 1992-02-04 Yuhe Yang Air actuated car curtain device
AU658441B2 (en) * 1991-07-23 1995-04-13 Schering Corporation Substituted beta-lactam compounds useful as hypocholesterolemic agents and processes for the preparation thereof

Also Published As

Publication number Publication date
CN1126989A (zh) 1996-07-17
WO1995001961A1 (en) 1995-01-19
JPH08507085A (ja) 1996-07-30
ATE205475T1 (de) 2001-09-15
DK0707567T3 (da) 2001-11-26
EP0707567A1 (en) 1996-04-24
NZ268798A (en) 1997-01-29
CA2166784C (en) 2001-12-11
HU9503748D0 (en) 1996-02-28
JP2840452B2 (ja) 1998-12-24
FI960095A0 (fi) 1996-01-09
PT707567E (pt) 2002-01-30
CZ7696A3 (en) 1996-04-17
FI960095L (fi) 1996-01-09
AU7214694A (en) 1995-02-06
ES2160125T3 (es) 2001-11-01
NO306294B1 (no) 1999-10-18
DE69428280T2 (de) 2002-06-13
KR960703853A (ko) 1996-08-31
KR0176001B1 (ko) 1999-03-20
FI960095A7 (fi) 1996-01-09
DE69428280D1 (de) 2001-10-18
MX9405152A (es) 1995-01-31
CN1071745C (zh) 2001-09-26
CA2166784A1 (en) 1995-01-19
NO960083L (no) 1996-03-04
PL312502A1 (en) 1996-04-29
EP0707567B1 (en) 2001-09-12
NO960083D0 (no) 1996-01-08
HUT73237A (en) 1996-07-29
US5728827A (en) 1998-03-17
AU681419B2 (en) 1997-08-28

Similar Documents

Publication Publication Date Title
EP0707567B1 (en) Process for the synthesis of azetidinones
US6093812A (en) Process for the stereospecific synthesis of azetidinones
US5561227A (en) Process for the stereospecific synthesis of azetidinones
JP3145993B2 (ja) 抗腫瘍化合物及びその調製方法
JPH03176468A (ja) イソインドロン誘導体
KR950013767B1 (ko) 키랄성 아제티디논 화합물 및 이의 제조방법
EP0336369A1 (en) 3-Acylamino-1-[[[(substituted sulfonyl)amino]carbonyl]amino]2-azetidinones
IE55839B1 (en) Azetidine compounds
US5804577A (en) Cephalosporin derivatives
EP0110280B1 (en) Process for the production of penem compounds
US6858727B2 (en) Intermediate of carbapenem antibiotics and process for the preparation thereof
US4559333A (en) Hydrazone substituted penems
EP0001715A2 (en) Azetidinone antibiotics and their pharmaceutical formulations and use
EP0793666A1 (en) Silylation process
FI83959B (fi) Foerfarande foer framstaellning av antibiotiskt aktiva 1-karba-(1-detia) cefalosporinderivat.
KR880001989B1 (ko) 펜엠 화합물의 제조방법
JPS61176563A (ja) 4,4‐ジアルキル‐2‐アゼチジノン類の製造法
US4587241A (en) Heterocyclic substituted penems
JP2696807B2 (ja) カルバペネム誘導体の製法
JPS6366187A (ja) 2α−置換ペニシリン誘導体
JPS59134796A (ja) 6−アミノペニシラン酸のテトラアルキルアンモニウム塩を用いる6−アミノペニシラン酸エステルの製造法
JPH0273057A (ja) カルバペネム系抗生物質合成用中間体の製造法
GB2276166A (en) Benzimidazoles as angiotensin II antagonists
JPH0572396B2 (cs)
JP2001514169A (ja) β−メチルカルバペネム中間体の製造